Biological effects of rAAV-caAlk2 coating on structural allograft healing

Molecular Therapy

Volumn 12, Issue 2, 2005, Pages 212-218

  Koefoed, Mette ^a   Ito, Hiromu ^a   Gromov, Kirill ^a   Reynolds, David G ^a   Awad, Hani A ^a   Rubery, Paul T ^a   Ulrich Vinther, Michael ^b   Soballe, Kjeld ^b   Guldberg, Robert E ^c   Lin, Angela S P ^c   O'Keefe, Regis J ^a   Zhang, Xinping ^a   Schwarz, Edward M ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Allograft; Bone morphogenetic protein; Recombinant adeno associated virus

Indexed keywords

ACTIVIN RECEPTOR 2; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE REMODELING; CALLUS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; FEMUR; FRACTURE HEALING; GENE TRANSFER; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; QUANTITATIVE ANALYSIS; REPORTER GENE; SIGNAL TRANSDUCTION; STUDENT T TEST; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LAC OPERON; MICE; TRANSPLANTATION, HOMOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

ADENO-ASSOCIATED VIRUS; MURINAE;

EID: 22644443111     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.02.026     Document Type: Article

References (38)

1. M.J. Yaszemski R.G. Payne W.C. Hayes R. Langer and A.G. Mikos Evolution of bone transplantation: Molecular, cellular and tissue strategies to engineer human bone Biomaterials 17 1996 175-185
2. D.S. Garbuz B.A. Masri and A.A. Czitrom Biology of allografting Orthop. Clin. North Am. 29 1998 199-204
3. S. Stevenson Biology of bone grafts Orthop. Clin. North Am. 30 1999 543-552
4. J.V. Deluca C. Cianelli and G.E. Friedlaender A comparative histomorphometric study of bone remodeling in human paired cancellous autografts and allografts Trans. Orthop. Res. Soc. 11 1987 376
5. E.M. Younger and M.W. Chapman Morbidity at bone graft donor sites J. Orthop. Trauma 3 1989 192-195
6. B.N. Summers and S.M. Eisenstein Donor site pain from the ilium: A complication of lumbar spine fusion J. Bone Joint Surg. (Br.) 71 1989 677-680
7. S. Stevenson J.W. Shaffer and V.M. Goldberg The humoral response to vascular and nonvascular allografts of bone Clin. Orthop. 1996 86-95
8. S. Stevenson X.Q. Li D.T. Davy L. Klein and V.M. Goldberg Critical biological determinants of incorporation of non-vascularized cortical bone grafts: Quantification of a complex process and structure J. Bone Joint Surg. Am. 79 1997 1-16
9. P. Tiyapatanaputi P.T. Rubery J. Carmouche E.M. Schwarz R.J. O'Keefe and X. Zhang A novel murine segmental femoral graft model J. Orthop. Res. 22 2004 1254-1260
10. T.A. Einhorn The cell and molecular biology of fracture healing Clin. Orthop. 1998 S7-S21
11. H. Burchardt Biology of bone transplantation Orthop. Clin. North Am. 18 1987 187-196
12. C.F. Lord M.C. Gebhardt W.W. Tomford and H.J. Mankin Infection in bone allografts: Incidence, nature, and treatment J. Bone Joint Surg. Am. 70 1988 369-376
13. B.H. Berrey Jr. C.F. Lord M.C. Gebhardt and H.J. Mankin Fractures of allografts: Frequency, treatment, and end-results J. Bone Joint Surg. Am. 72 1990 825-833
14. J.R. Lieberman A. Daluiski and T.A. Einhorn The role of growth factors in the repair of bone: Biology and clinical applications J. Bone Joint Surg. Am. 84-A 2002 1032-1044
15. Y. Gafni G. Turgeman M. Liebergal G. Pelled Z. Gazit and D. Gazit Stem cells as vehicles for orthopedic gene therapy Gene Ther. 11 2004 417-426
16. T.A. Einhorn Clinical applications of recombinant human BMPs: Early experience and future development J. Bone Joint Surg. Am. 85-A Suppl. 3 2003 82-88
17. J.R. Lieberman S.C. Ghivizzani and C.H. Evans Gene transfer approaches to the healing of bone and cartilage Mol. Ther. 6 2002 141-147
18. A.W. Baltzer and J.R. Lieberman Regional gene therapy to enhance bone repair Gene Ther. 11 2004 344-350
19. Y. Chen et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors Gene Ther. 10 2003 1345-1353
20. K.D. Luk Y. Chen K.M. Cheung H.F. Kung W.W. Lu and J.C. Leong Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation Biochem. Biophys. Res. Commun. 308 2003 636-645
21. Y. Gafni et al. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system Mol. Ther. 9 2004 587-595
22. Y. Chen A. Bhushan and W. Vale Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase Proc. Natl. Acad. Sci. USA 94 1997 12938-12943
23. D. Zhang E.M. Schwarz R.N. Rosier M.J. Zuscik J.E. Puzas and R.J. O'Keefe ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development J. Bone Miner. Res. 18 2003 1593-1604
24. H. Ito Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy Nat. Med. 11 2005 291-297
25. R.E. Guldberg et al. Analyzing bone, blood vessels, and biomaterials with microcomputed tomography IEEE Eng. Med. Biol. Magn. 22 2003 77-83
26. J. Bonadio E. Smiley P. Patil and S. Goldstein Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration Nat. Med. 5 1999 753-759
27. E.M. Schwarz The adeno-associated virus vector for orthopaedic gene therapy Clin. Orthop. Relat. Res. 379S 2000 S31-S39
28. J.E. Rabinowitz and R.J. Samulski Building a better vector: The manipulation of AAV virions Virology 278 2000 301-308
29. D. Gazit et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy J. Gene Med. 1 1999 121-133
30. I.K. Moutsatsos et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration Mol. Ther. 3 2001 449-461
31. G. Turgeman et al. Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy J. Gene Med. 3 2001 240-251
32. H.P. Gerber T.H. Vu A.M. Ryan J. Kowalski Z. Werb and N. Ferrara VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation Nat. Med. 5 1999 623-628
33. R.E. Guldberg A.S. Lin R. Coleman G. Robertson and C. Duvall Microcomputed tomography imaging of skeletal development and growth Birth Defects Res. C Embryo Today 72 2004 250-259
34. C.L. Duvall W. Robert Taylor D. Weiss and R.E. Guldberg Quantitative microcomputed tomography analysis of collateral vessel development after ischemic injury Am. J. Physiol. Heart Circ. Physiol. 287 2004 H302-H310
35. X. Xiao J. Li and R.J. Samulski Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J. Virol. 72 1998 2224-2232
36. J. Goater et al. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis J. Rheumatol. 27 2000 983-989
37. L.M. Childs J.J. Goater R.J. O'Keefe and E.M. Schwarz Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis J. Bone Joint Surg. Am. 83-A 2001 1789-1797
38. X. Zhang E.M. Schwarz D.A. Young J.E. Puzas R.N. Rosier and R.J. O'Keefe Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair J. Clin. Invest. 109 2002 1405-1415